Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature

被引：0
|
作者：
Huanhuan Xu
Qi Liang
Xian Xu
Shanyue Tan
Sumeng Wang
Yiqian Liu
Lingxiang Liu
机构：
[1] The First Affiliated Hospital of Nanjing Medical University,Department of Oncology
来源：
World Journal of Surgical Oncology | / 19卷
关键词：
Afatinib; Anlotinib; HER2 mutation; Lung adenocarcinoma; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Anlotinib combined with temozolomide for the treatment of patients with diffuse midline glioma: a case report and literature review
    Feng, Yiping
    Xu, Qingsheng
    Fang, Minwei
    Hu, Chi
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, : 3876 - 3882
  • [32] Anlotinib combined with radiotherapy and chemotherapy for recurrent pelvic osteosarcoma treatment: a case report and literature review
    Chen, Qian
    Zheng, Kai
    Xu, Ming
    Yan, Ning
    Hai, Gong
    Yu, Xiuchun
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] HER2 exon 20 insertion mutations and myelosuppression in lung adenocarcinoma patient: a case report and response to trastuzumab deruxtecan
    Bin Wang
    Yang Song
    Xin Yang
    Chuan Chen
    [J]. Journal of Cardiothoracic Surgery, 18
  • [34] HER2 exon 20 insertion mutations and myelosuppression in lung adenocarcinoma patient: a case report and response to trastuzumab deruxtecan
    Wang, Bin
    Song, Yang
    Yang, Xin
    Chen, Chuan
    [J]. JOURNAL OF CARDIOTHORACIC SURGERY, 2023, 18 (01)
  • [35] A case of lung adenocarcinoma with a concurrent EGFR mutation and ALK rearrangement: A case report and literature review
    Xu, Chun-Wei
    Cai, Xue-Ying
    Shao, Yuan
    Li, Yang
    Shi, Ming-Wei
    Zhang, Li-Ying
    Wang, Lin
    Zhang, Yu-Ping
    Wang, Lu-Ping
    Tian, Yu-Wang
    [J]. MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 4370 - 4375
  • [36] Cutaneous lymphangitis carcinomatosa in a patient with lung adenocarcinoma: Case report and literature review
    Prat, Lola
    Chouaid, Christos
    Kettaneh, Adrien
    Fardet, Laurence
    [J]. LUNG CANCER, 2013, 79 (01) : 91 - 93
  • [37] Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature
    Harada, Kazuaki
    Ogasawara, Makoto
    Shido, Akane
    Meno, Akimitsu
    Oda, Soichiro
    Yoshida, Shota
    Yoshida, Sonoe
    Yoshikawa, Ayumu
    Ebata, Ko
    Abiko, Satoshi
    Kawagishi, Naoki
    Sano, Itsuki
    Oda, Hisashi
    Miyagishima, Takuto
    [J]. THORACIC CANCER, 2020, 11 (05) : 1350 - 1353
  • [38] Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report
    Chen, Xuesong
    Zha, Wangjian
    Su, Mei
    Meng, Nan
    Cao, Shuliang
    Niu, Beifang
    Qi, Xu
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [39] Apatinib for treatment of HGF in advanced lung adenocarcinoma harboring EGFR activating mutation: a case report and review of literature
    Zhang, Jie
    Gu, Ting-Ting
    Li, Xiao-Xiao
    Wang, Cai-Hua
    Zeng, Da-Xiong
    Wang, Chang-Guo
    Huang, Jian-An
    Jiang, Jun-Hong
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 1094 - 1100
  • [40] Case Series of HER2 Mutated Metastatic Lung Adenocarcinoma and Response to HER2 Targeted Therapies
    Chuang, Jody
    Neal, Joel W.
    Wakelee, Heather A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S549 - S549
12345